Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Antonia Chadwick

Geriatric Medicine Chambersburg, PA Medical Doctor

NPI 1558389452 CMS profile 115408

435 Phoenix Dr, Chambersburg, PA 17201

Open in the dashboard

General payments

$4,168

292 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Antonia Chadwick of Chambersburg, PA is reported in the CMS Open Payments database as having received $4,168 across 292 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $1,097 67
2020 General $1,481 103
2019 General $1,590 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Antonia Chadwick
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to Antonia Chadwick were reported at $0. Among 1,028 Geriatric Medicine profiles paid that year, the median was $123 and the middle half received between $35 and $408.

Show as a table
Year Antonia Chadwick Geriatric Medicine median Middle half National median
2019 $1,590 $122 $40–$435 $163
2020 $1,481 $98 $25–$349 $114
2021 $1,097 $125 $34–$441 $132
2022 $0 $124 $36–$408 $149
2023 $0 $121 $41–$383 $160
2024 $0 $134 $41–$435 $164
2025 $0 $123 $35–$408 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Pfizer Inc. $679 51 payments
  2. Novo Nordisk Inc $571 42 payments
  3. AstraZeneca Pharmaceuticals LP $362 22 payments
  4. Lilly USA, LLC $317 21 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $289 20 payments
  6. Janssen Pharmaceuticals, Inc $249 18 payments
  7. AbbVie, Inc. $245 13 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $214 18 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $191 12 payments
  10. Merck Sharp & Dohme Corporation $163 10 payments
  11. Other $889 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $4,168 292 payments
Products named General payments · program years 2019–2021
  1. ELIQUIS $445 31 payments
  2. Ozempic $425 31 payments
  3. XIFAXAN $289 20 payments
  4. RYBELSUS $288 19 payments
  5. TRULICITY $259 18 payments
  6. FARXIGA $251 15 payments
  7. XARELTO $249 18 payments
  8. INVOKANA $231 17 payments
  9. JARDIANCE $219 15 payments
  10. Tresiba $184 14 payments
  11. Other $3,312 234 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

292 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Medicine in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record